RMD - יחס שווי שוק לרווח וקצב צמיחה ResMed Corporation

ResMed Inc. (RMD) leads in digital sleep monitoring by creating smart cloud services for remote diagnostics. Stable demand for apnea therapy equipment ensures high macro-resilience for the business. Patents and FDA certifications create significant barriers to entry. The ratio of valuation to business expansion rates on this chart clearly demonstrates the trend, where the 1.94 mark characterizes this parameter.

When constructing a long-term portfolio, asset screening requires aligning market valuation with earnings expansion rates. This indicator divides the P/E ratio by the annual earnings growth rate to determine the degree of business overvaluation; in the case of ResMed Inc. (RMD), the risk of regulatory pressure and component shortages may distort the P/E-to-growth dynamics, generating false signals of undervaluation.